Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1054

1.

Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: association with E-cadherin1 (CDH1) promoter methylation.

Saito T, Mizukami H, Umetsu S, Uchida C, Inaba W, Abe M, Takahashi K, Kudo K, Itabashi C, Yagihashi S, Hakamada K.

Sci Rep. 2017 Dec 22;7(1):18056. doi: 10.1038/s41598-017-18438-z.

2.

Development of diagnostic model of lung cancer based on multiple tumor markers and data mining.

Wang Z, Feng F, Zhou X, Duan L, Wang J, Wu Y, Wang N.

Oncotarget. 2017 Oct 19;8(55):94793-94804. doi: 10.18632/oncotarget.21935. eCollection 2017 Nov 7.

3.

Hepatitis C virus Core overcomes all-trans retinoic acid-induced apoptosis in human hepatoma cells by inhibiting p14 expression via DNA methylation.

Kwak J, Choi JH, Jang KL.

Oncotarget. 2017 Aug 18;8(49):85584-85598. doi: 10.18632/oncotarget.20337. eCollection 2017 Oct 17.

4.

Childhood Adversities are not a Predictors of SSTR4met in Alcoholics.

Berent D, Pogórski M, Kulczycka-Wojdala D, Kusideł E, Macander M, Pawłowska Z.

Transl Neurosci. 2017 Oct 29;8:127-138. doi: 10.1515/tnsci-2017-0019. eCollection 2017.

5.

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer.

Chüeh AC, Liew MS, Russell PA, Walkiewicz M, Jayachandran A, Starmans MHW, Boutros PC, Wright G, Barnett SA, Mariadason JM, John T.

Oncotarget. 2017 May 23;8(43):74036-74048. doi: 10.18632/oncotarget.18198. eCollection 2017 Sep 26.

6.

Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.

Guo Y, Peng Y, Gao D, Zhang M, Yang W, Linghu E, Herman JG, Fuks F, Dong G, Guo M.

Clin Epigenetics. 2017 Oct 23;9:116. doi: 10.1186/s13148-017-0412-9. eCollection 2017.

7.

Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.

Wang Y, He T, Herman JG, Linghu E, Yang Y, Fuks F, Zhou F, Song L, Guo M.

Clin Epigenetics. 2017 Oct 18;9:115. doi: 10.1186/s13148-017-0417-4. eCollection 2017.

8.

Hypermethylation in the promoter of the MTHFR gene is associated with diabetic complications and biochemical indicators.

Dos Santos Nunes MK, Silva AS, de Queiroga Evangelista IW, Filho JM, Gomes CNAP, do Nascimento RAF, Luna RCP, de Carvalho Costa MJ, de Oliveira NFP, Persuhn DC.

Diabetol Metab Syndr. 2017 Oct 18;9:84. doi: 10.1186/s13098-017-0284-3. eCollection 2017.

9.

Harmine, a Novel DNA Methyltransferase 1 Inhibitor in the Leukemia Cell Line.

Oodi A, Norouzi H, Amirizadeh N, Nikougoftar M, Vafaie Z.

Indian J Hematol Blood Transfus. 2017 Dec;33(4):509-515. doi: 10.1007/s12288-016-0770-z. Epub 2017 Jan 17.

PMID:
29075061
10.

Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.

Wang Y, Zhang Y, Herman JG, Linghu E, Guo M.

Oncotarget. 2017 Jul 25;8(41):70035-70048. doi: 10.18632/oncotarget.19550. eCollection 2017 Sep 19.

11.

Evaluation of p16INK4α Hypermethylation from Liquid-based Pap Test Samples in Vietnamese Population.

Truong PK, Lao TD, LE TAH.

Iran J Public Health. 2017 Sep;46(9):1204-1210.

12.

Analysis of Promyelocytic Leukemia in Human Embryonic Carcinoma Stem Cells During Retinoic Acid-Induced Neural Differentiation.

Karbalaie K, Vallian S, Lachinani L, Tanhaei S, Baharvand H, Nasr-Esfahani MH.

Iran J Biotechnol. 2016 Sep;14(3):169-176. doi: 10.15171/ijb.1358.

13.

Oral Contraceptive Use May Modulate Global Genomic DNA Methylation and Promoter Methylation of APC1 and ESR1

Moradi Sarabi M, Ghareghani P, Khademi F, Zal F.

Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2361-2366.

14.

Prader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive Medicine.

Kubota T, Miyake K, Hariya N, Tran Nguyen Quoc V, Mochizuki K.

Diseases. 2016 Mar 11;4(1). pii: E15. doi: 10.3390/diseases4010015. Review.

15.

Current approaches on non-invasive prenatal diagnosis: Prenatal genomics, transcriptomics, personalized fetal diagnosis.

Günel T, Hosseini MK, Gümüşoğlu E, Zeybek G, Dölekçap İ, Kalelioğlu İ, Benian A, Ermiş H, Aydınlı K.

Turk J Obstet Gynecol. 2014 Dec;11(4):233-241. doi: 10.4274/tjod.26817. Epub 2014 Dec 15. Review.

16.

Highly sensitive and multiplexed analysis of CpG methylation at single-base resolution with ligation-based exponential amplification.

Su F, Wang L, Sun Y, Liu C, Duan X, Li Z.

Chem Sci. 2015 Mar 1;6(3):1866-1872. doi: 10.1039/c4sc03135k. Epub 2014 Dec 11.

17.

Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer.

Wang B, Yu L, Luo X, Huang L, Li QS, Shao XS, Liu Y, Fan Y, Yang GZ.

Oncol Lett. 2017 Jul;14(1):217-223. doi: 10.3892/ol.2017.6111. Epub 2017 May 3.

18.

The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis.

Liu D, Peng H, Sun Q, Zhao Z, Yu X, Ge S, Wang H, Fang H, Gao Q, Liu J, Wu L, Song M, Wang Y.

Int J Environ Res Public Health. 2017 Jun 23;14(7). pii: E679. doi: 10.3390/ijerph14070679. Review.

19.

Reliability and performance of commercial RNA and DNA extraction kits for FFPE tissue cores.

Patel PG, Selvarajah S, Guérard KP, Bartlett JMS, Lapointe J, Berman DM, Okello JBA, Park PC.

PLoS One. 2017 Jun 22;12(6):e0179732. doi: 10.1371/journal.pone.0179732. eCollection 2017.

20.

The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.

Demurtas L, Puzzoni M, Giampieri R, Ziranu P, Pusceddu V, Mandolesi A, Cremolini C, Masi G, Gelsomino F, Antoniotti C, Loretelli C, Meriggi F, Zaniboni A, Falcone A, Cascinu S, Scartozzi M.

Br J Cancer. 2017 Jul 25;117(3):315-321. doi: 10.1038/bjc.2017.178. Epub 2017 Jun 20.

PMID:
28632725

Supplemental Content

Support Center